Göpel, Wolfgang http://orcid.org/0000-0002-6486-4727
Rausch, Tanja K.
Mitschdörfer, Barbara
Mader, Silke
Herting, Egbert
König, Inke R.
Stichtenoth, Guido
Höhn, Thomas
Stein, Anja
Bayer, Hagen
Schmidtke, Susanne
Naust, Barabara
Roll, Claudia
Franz, Axel
Wolff, Moritz
Siemes, Anna
Schneider, Katja
Dieks, Jana Katharina
Fuchs, Hans
Körner, Thorsten
Schroth, Michael
Dohle, Frank
Völkl, Thomas
Härtel, Christoph
Bejo, Levente
Schneider, Welfhard
,
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (01KG2024)
Universität zu Lübeck
Article History
Received: 5 June 2023
Accepted: 25 August 2023
First Online: 26 September 2023
Declarations
:
: Written informed consent to participate will be obtained from all legal guardians of preterm infants participating in the pro.LISA trial. The pro.LISA trial was approved by the Ethics Committee of the University of Lübeck (No.: 21–422) and by ethics committees of all participating sites.
: A consent form which is revised and adapted by the Ethics Committees of participating centres is part of the informed consent process. This consent form includes information about the purpose of the trial, the potential benefits and risks, the right to refuse participation or to withdraw consent at any time, the institutional affiliation and potential competing interests of the researcher, and the sources of trial funding. Model consent forms (in German language) are available on reasonable request from the principal investigator.
: WG, IRK, and EH report grants from the Federal Ministry of Education and Research, Germany. WG, EH, and GS report personal fees from Chiesi Farmaceutici SpA outside the submitted work. All other authors declare that they have no competing interests.